Mattia Forcato

19PUBLICATIONS
100CO-AUTHORS
Haematological tumoursInnate immunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 11, 2026
A specific stem cell program and CD112 immunological axis dysfunctions underpinning monosomy 7-associated myeloid neoplasms.

|Oct 03, 2025
Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells.

Benedetta De Ponte Conti, Rebecca Marino, Tanja Rezzonico-Jost

|Jun 11, 2024
The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer.

Martina Dragonetti, Chiara Turco, Anna Benedetti

|Mar 20, 2024
Oncogenic enhancers prime quiescent metastatic cells to escape NK immune surveillance by eliciting transcriptional memory.

Daniela Michelatti, Sven Beyes, Chiara Bernardis

|Apr 11, 2023
ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis.

Erna Marija Meškytė, Laura Pezzè, Laura Bartolomei

|Jun 29, 2022
YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS-STING.

Hanna Lucie Sladitschek-Martens, Alberto Guarnieri, Giulia Brumana

Pageof 4

Frequent Collaborators

14 joint publications

Silvio Bicciato

4 joint publications

Stefano Piccolo

3 joint publications

Matteo Fassan

3 joint publications

Giovanna Brusatin